Here it is: Below are additional sites now enrolling patients for the Phase 3 nivolumab trial known as -037. I also see that the clinicaltrial.gov listing is now showing the locations: http://www.clinicaltrials.gov/ct2/show/NCT01721746?term=bms-936558&phase=2&rank=1.
Jeffrey Infante, MD
Tennessee Oncology, PLLC
250 25th Avenue North, Suite 307
Nashville, TN 37203
F. Stephen Hodi, M.D.
Dana Farber Cancer Institute
450 Brookline Ave
Boston, MA 02215
Jeffrey Sosman, MD
Vanderbilt-Ingram Cancer Center
2220 Pierce Ave, 777 Preston Research Building
Nashville, TN 37232
Jeffrey Weber, MD, PhD
H. Lee Moffitt Cancer Center & Research Institute, Inc
12902 Magnolia Dr
Tampa, Florida 33612
Gerry Linette
Washington University School of Medicine in St. Louis